Stock Market Today, Feb. 4: Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors

Market Intelligence Analysis

AI-Powered
Why This Matters

Boston Scientific's stock price has plummeted due to its cautious 2026 guidance, disappointing investors. The company's guidance has raised concerns about its long-term margin path and new deals. Investors are weighing the implications of this guidance on the company's future performance.

Market Impact

Market impact analysis based on bearish sentiment with 90% confidence.

Sentiment
Bearish
AI Confidence
90%
Time Horizon
Short Term

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

Today, Feb. 4, 2026, investors are weighing Boston Scientific’s guidance against new deals and its long-term margin path.

Continue Reading
Full article on Yahoo Finance
Read Full Article
Original article published by Yahoo Finance on February 5, 2026.
Analysis and insights provided by AnalystMarkets AI.